Abnormal (Dysfunctional) Uterine Bleeding in Pediatrics Differential Diagnoses

1. Bravender T, Emans SJ. Menstrual disorders. Dysfunctional uterine bleeding. Pediatr Clin North Am. 1999 Jun. 46 (3):545-53, viii. [QxMD MEDLINE Link].

2. Coupey SM, Ahlstrom P. Common menstrual disorders. Pediatr Clin North Am. 1989 Jun. 36 (3):551-71. [QxMD MEDLINE Link].

3. Yaşa C, Güngör Uğurlucan F. Approach to Abnormal Uterine Bleeding in Adolescents. J Clin Res Pediatr Endocrinol. 2020 Feb 6. 12 (Suppl 1):1-6. [QxMD MEDLINE Link]. [Full Text].

4. Lavin C. Dysfunctional uterine bleeding in adolescents. Curr Opin Pediatr. 1996 Aug. 8 (4):328-32. [QxMD MEDLINE Link].

5. Minjarez DA, Bradshaw KD. Abnormal uterine bleeding in adolescents. Obstet Gynecol Clin North Am. 2000 Mar. 27 (1):63-78. [QxMD MEDLINE Link].

6. Strickland J, Gibson EJ, Levine SB. Dysfunctional uterine bleeding in adolescents. J Pediatr Adolesc Gynecol. 2006 Feb. 19 (1):49-51. [QxMD MEDLINE Link].

7. Munro MG, Critchley HO, Broder MS, Fraser IS, FIGO Working Group on Menstrual Disorders. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynaecol Obstet. 2011 Apr. 113 (1):3-13. [QxMD MEDLINE Link]. [Full Text].

8. Davila J, Alderman EM. Heavy Menstrual Bleeding in Adolescent Girls. Pediatr Ann. 2020 Apr 1. 49 (4):e163-e169. [QxMD MEDLINE Link].

9. Mullins TL, Miller RJ, Mullins ES. Evaluation and Management of Adolescents with Abnormal Uterine Bleeding. Pediatr Ann. 2015 Sep. 44 (9):e218-22. [QxMD MEDLINE Link]. [Full Text].

10. Elmaoğulları S, Aycan Z. Abnormal Uterine Bleeding in Adolescents. J Clin Res Pediatr Endocrinol. 2018 Jul 31. 10 (3):191-197. [QxMD MEDLINE Link]. [Full Text].

11. Munro MG, Critchley HOD, Fraser IS, FIGO Menstrual Disorders Committee. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions. Int J Gynaecol Obstet. 2018 Dec. 143 (3):393-408. [QxMD MEDLINE Link]. [Full Text].

12. ESHRE Capri Workshop Group., Collins J, Crosignani PG. Endometrial bleeding. Hum Reprod Update. 2007 Sep-Oct. 13 (5):421-31. [QxMD MEDLINE Link].

13. Austin SB, Ziyadeh NJ, Vohra S, Forman S, Gordon CM, Prokop LA, et al. Irregular menses linked to vomiting in a nonclinical sample: findings from the National Eating Disorders Screening Program in high schools. J Adolesc Health. 2008 May. 42 (5):450-7. [QxMD MEDLINE Link]. [Full Text].

14. American Academy of Pediatrics Committee on Adolescence., American College of Obstetricians and Gynecologists Committee on Adolescent Health Care., Diaz A, Laufer MR, Breech LL. Menstruation in girls and adolescents: using the menstrual cycle as a vital sign. Pediatrics. 2006 Nov. 118 (5):2245-50. [QxMD MEDLINE Link].

15. Martinez GM. Trends and Patterns in Menarche in the United States: 1995 through 2013-2017. Natl Health Stat Report. 2020 Sep. 1-12. [QxMD MEDLINE Link].

16. Al-Sahab B, Ardern CI, Hamadeh MJ, Tamim H. Age at menarche in Canada: results from the National Longitudinal Survey of Children & Youth. BMC Public Health. 2010 Nov 28. 10:736. [QxMD MEDLINE Link]. [Full Text].

17. Morris DH, Jones ME, Schoemaker MJ, Ashworth A, Swerdlow AJ. Secular trends in age at menarche in women in the UK born 1908-93: results from the Breakthrough Generations Study. Paediatr Perinat Epidemiol. 2011 Jul. 25 (4):394-400. [QxMD MEDLINE Link].

18. Mikhail S, Kouides P. von Willebrand disease in the pediatric and adolescent population. J Pediatr Adolesc Gynecol. 2010 Dec. 23 (6 Suppl):S3-10. [QxMD MEDLINE Link].

19. James AH. Women and bleeding disorders. Haemophilia. 2010 Jul. 16 Suppl 5:160-7. [QxMD MEDLINE Link].

20. Maslyanskaya S, Talib HJ, Northridge JL, Jacobs AM, Coble C, Coupey SM. Polycystic Ovary Syndrome: An Under-recognized Cause of Abnormal Uterine Bleeding in Adolescents Admitted to a Children's Hospital. J Pediatr Adolesc Gynecol. 2017 Jun. 30 (3):349-355. [QxMD MEDLINE Link].

21. Braverman PK, Breech L, Committee on Adolescence. American Academy of Pediatrics. Clinical report--gynecologic examination for adolescents in the pediatric office setting. Pediatrics. 2010 Sep. 126 (3):583-90. [QxMD MEDLINE Link].

22. Meirow D, Rabinovici J, Katz D, Or R, Shufaro Y, Ben-Yehuda D. Prevention of severe menorrhagia in oncology patients with treatment-induced thrombocytopenia by luteinizing hormone-releasing hormone agonist and depo-medroxyprogesterone acetate. Cancer. 2006 Oct 1. 107 (7):1634-41. [QxMD MEDLINE Link].

23. Toth M, Patton DL, Esquenazi B, Shevchuk M, Thaler H, Divon M. Association between Chlamydia trachomatis and abnormal uterine bleeding. Am J Reprod Immunol. 2007 May. 57 (5):361-6. [QxMD MEDLINE Link].

24. Lee DY, Oh YK, Yoon BK, Choi D. Prevalence of hyperprolactinemia in adolescents and young women with menstruation-related problems. Am J Obstet Gynecol. 2012 Mar. 206 (3):213.e1-5. [QxMD MEDLINE Link].

25. [Guideline] The diagnosis, evaluation and management of von Willebrand disease. National Heart Lung and Blood Institute (NHLBI). Available at https://www.nhlbi.nih.gov/files/docs/guidelines/vwd.pdf. December 2007; Accessed: June 17, 2021.

26. [Guideline] ACR Appropriateness Criteria® abnormal vaginal bleeding. American College of Radiology. Available at https://acsearch.acr.org/docs/69458/Narrative/. 2020; Accessed: June 17, 2021.

27. Bumbuliene Z, Sragyte D, Klimasenko J, Bumbul-Mazurek E. Abnormal uterine bleeding in adolescents: ultrasound evaluation of uterine volume. Gynecol Endocrinol. 2019 Apr. 35 (4):356-359. [QxMD MEDLINE Link].

28. Pecchioli Y, Oyewumi L, Allen LM, Kives S. The Utility of Routine Ultrasound in the Diagnosis and Management of Adolescents with Abnormal Uterine Bleeding. J Pediatr Adolesc Gynecol. 2017 Apr. 30 (2):239-242. [QxMD MEDLINE Link].

29. [Guideline] Committee on Practice Bulletins—Gynecology. Practice bulletin no. 136: management of abnormal uterine bleeding associated with ovulatory dysfunction. Obstet Gynecol. 2013 Jul. 122 (1):176-85. [QxMD MEDLINE Link].

30. Casablanca Y. Management of dysfunctional uterine bleeding. Obstet Gynecol Clin North Am. 2008 Jun. 35 (2):219-34, viii. [QxMD MEDLINE Link].

31. Stabinsky SA, Einstein M, Breen JL. Modern treatments of menorrhagia attributable to dysfunctional uterine bleeding. Obstet Gynecol Surv. 1999 Jan. 54 (1):61-72. [QxMD MEDLINE Link].

32. Kadir RA, Edlund M, Von Mackensen S. The impact of menstrual disorders on quality of life in women with inherited bleeding disorders. Haemophilia. 2010 Sep 1. 16 (5):832-9. [QxMD MEDLINE Link].

33. Rajput R, Dhuan J, Agarwal S, Gahlaut PS. Central venous sinus thrombosis in a young woman taking norethindrone acetate for dysfunctional uterine bleeding: case report and review of literature. J Obstet Gynaecol Can. 2008 Aug. 30 (8):680-683. [QxMD MEDLINE Link].

34. Gultekin M, Diribaş K, Buru E, Gökçeoğlu MA. Role of a non-hormonal oral anti-fibrinolytic hemostatic agent (tranexamic acid) for management of patients with dysfunctional uterine bleeding. Clin Exp Obstet Gynecol. 2009. 36 (3):163-5. [QxMD MEDLINE Link].

35. Bs D, Nanda SK. The role of sevista in the management of dysfunctional uterine bleeding. J Clin Diagn Res. 2013 Jan. 7 (1):132-4. [QxMD MEDLINE Link]. [Full Text].

Germaine L Defendi, MD, MS, FAAP Associate Clinical Professor, Department of Pediatrics, Olive View-UCLA Medical Center

Germaine L Defendi, MD, MS, FAAP is a member of the following medical societies: American Academy of Pediatrics

Disclosure: Nothing to disclose.

Mary L Windle, PharmD Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Wayne Wolfram, MD, MPH Professor, Department of Emergency Medicine, Mercy St Vincent Medical Center; Chairman, Pediatric Institutional Review Board, Mercy St Vincent Medical Center, Toledo, Ohio

Wayne Wolfram, MD, MPH is a member of the following medical societies: American Academy of Emergency Medicine, American Academy of Pediatrics, Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Andrea L Zuckerman, MD Associate Professor of Obstetrics/Gynecology, Tufts University School of Medicine; Division Director, Pediatric and Adolescent Gynecology, Tufts Medical Center

Andrea L Zuckerman, MD is a member of the following medical societies: American College of Obstetricians and Gynecologists, Massachusetts Medical Society, North American Society for Pediatric and Adolescent Gynecology

Disclosure: Nothing to disclose.

Elizabeth Alderman, MD Director, Pediatric Residency Program, Director of Fellowship Training Program, Adolescent Medicine, Professor of Clinical Pediatrics, Department of Pediatrics, Division of Adolescent Medicine, Albert Einstein College of Medicine and Children's Hospital at Montefiore

Elizabeth Alderman, MD is a member of the following medical societies: American Academy of Pediatrics, American Pediatric Society, North American Society for Pediatric and Adolescent Gynecology, Society for Adolescent Health and Medicine

Disclosure: Nothing to disclose.

The authors and editors of Medscape Drugs & Diseases gratefully acknowledge the contributions of previous authors Tod C Aeby, MD, and LeighAnn C Frattarelli, MD, MPH, to the development and writing of this article.

• Print this section
• Print the entire contents of
• Print the entire contents of article